Lacticaseibacillus rhamnosus PB01
Lacticaseibacillus rhamnosus PB01 is a lactic acid bacterium studied for its antimicrobial and metabolic properties. Animal models and in vitro research have examined the strain's effects on glucose metabolism and antifungal activity, with a recent randomized controlled trial investigating its potential in periodontal health. Human evidence remains preliminary, with most published research limited to preclinical models.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 4 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 3 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
5 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
PMID 42076937 →Probiotics Augment the Effect of Non‐Surgical Periodontal Treatment—A Randomised, Double‐Blinded, Placebo‐Controlled Trial· Journal Of Clinical Periodontology · 2026